Insider Transactions in Q3 2021 at Bio Techne Corp (TECH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
822
-100.0%
|
$434,838
$529.04 P/Share
|
|
Sep 07
2021
|
Randolph C Steer Director |
SELL
Open market or private sale
|
Direct |
8,000
-25.36%
|
$4,080,000
$510.34 P/Share
|
|
Sep 07
2021
|
Randolph C Steer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+26.94%
|
$712,000
$89.58 P/Share
|
|
Sep 02
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,871
-26.84%
|
$3,504,210
$510.25 P/Share
|
|
Sep 02
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,871
+32.16%
|
$858,875
$125.05 P/Share
|
|
Sep 02
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-23.99%
|
$5,080,000
$508.2 P/Share
|
|
Sep 02
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+32.41%
|
$1,060,000
$106.59 P/Share
|
|
Sep 02
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,005
-17.6%
|
$21,422,550
$510.78 P/Share
|
|
Sep 02
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,492
+23.55%
|
$7,937,136
$108.49 P/Share
|
|
Aug 31
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-14.76%
|
$2,520,000
$504.87 P/Share
|
|
Aug 31
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+28.38%
|
$625,000
$125.05 P/Share
|
|
Aug 31
2021
|
Norman David Eansor President-Protein Sciences |
SELL
Open market or private sale
|
Direct |
1,538
-53.85%
|
$773,614
$503.07 P/Share
|
|
Aug 23
2021
|
Robert V Baumgartner Director |
SELL
Open market or private sale
|
Direct |
4,000
-5.55%
|
$1,940,000
$485.27 P/Share
|
|
Aug 23
2021
|
Robert V Baumgartner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+22.71%
|
$348,000
$87.39 P/Share
|
|
Aug 23
2021
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
4,000
-37.16%
|
$1,924,000
$481.52 P/Share
|
|
Aug 23
2021
|
Roeland Nusse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+27.09%
|
$280,000
$70.35 P/Share
|
|
Aug 19
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,538
-11.81%
|
$1,677,012
$474.08 P/Share
|
|
Aug 19
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
4,337
+16.07%
|
$498,755
$115.82 P/Share
|
|
Aug 11
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
921
+0.55%
|
$99,468
$108.49 P/Share
|
|
Aug 09
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-7.51%
|
$4,800,000
$480.97 P/Share
|
|
Aug 09
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+32.41%
|
$1,060,000
$106.59 P/Share
|
|
Aug 08
2021
|
Norman David Eansor President-Protein Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-25.91%
|
$480,519
$481.82 P/Share
|
|
Aug 08
2021
|
Norman David Eansor President-Protein Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
2,537
+39.69%
|
-
|
|
Aug 08
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
677
-9.03%
|
$325,637
$481.82 P/Share
|
|
Aug 08
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,374
+15.49%
|
-
|
|
Aug 08
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
869
-51.39%
|
$417,989
$481.82 P/Share
|
|
Aug 08
2021
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,691
+50.0%
|
-
|
|
Aug 08
2021
|
James Hippel CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,665
-13.3%
|
$800,865
$481.82 P/Share
|
|
Aug 08
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,383
+21.27%
|
-
|
|
Aug 06
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,475
-7.06%
|
$6,000,475
$481.82 P/Share
|
|
Aug 06
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,918
+8.74%
|
-
|
|
Aug 06
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.24%
|
-
|
|
Jul 12
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-5.45%
|
$4,570,000
$457.8 P/Share
|
|
Jul 12
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.32%
|
$1,060,000
$106.59 P/Share
|